Clinical Trials Logo

Clinical Trial Summary

PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site: A Non-Inferiority Trial


Clinical Trial Description

A prospective single-blind study, where the evaluator is blinded to the treatment. Each patient will be dressed with both Aquacel® and PRF dressing. Half of the donor site area will be dressed with PRF dressing, and half with Aquacel®. 3 days after surgery the patients will be asked to complete a VAS questionnaire. A week and 2 weeks after surgery, patients will have their dressing changed as in the first treatment, and will answer VAS(9) and bluebelle(10) questionnaires. The wound will be photographed again for follow-up. Three weeks, 6 weeks and 3 months after surgery the scar in the donor area will be evaluated. The photographs will be shown to the blinded evaluator, to evaluate wound healing by epithelialization estimation. ;


Study Design


Related Conditions & MeSH terms

  • Treatment of Skin Graft Donor Site

NCT number NCT04749940
Study type Interventional
Source Rambam Health Care Campus
Contact
Status Withdrawn
Phase N/A
Start date January 1, 2021
Completion date June 1, 2021